Skip to content

Olga Valverde

11 papers in the library · 123 citations · publishing 1999-2015

Papers

Sort Most recent Most cited

Reduced Contextual Discrimination following Alcohol Consumption or MDMA Administration in Mice.

PLoS One 2015 Emily M Johansson, María S García-Gutiérrez, Maria Moscoso‐castro et al.

The recreational drugs, alcohol and 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") have both been shown to cause immune activation in vivo, and they are linked to cognitive impairment and anxiety-like behaviors in rodents. The neuronal effects of these drugs in the hippocampal area, an area that has been a focus of studies aiming to explain the mechanisms underlying anxiety...

Memory impairment and hippocampus specific protein oxidation induced by ethanol intake and 3, 4‐Methylenedioxymethamphetamine (MDMA) in mice

Journal of Neurochemistry March 25, 2013 Clara Ros‐simó, Maria Moscoso‐castro, Jéssica Ruiz‐medina et al. 35 citations

Abstract Ethanol and 3, 4‐Methylenedioxymethamphetamine ( MDMA ) are popular recreational drugs widely abused by adolescents that may induce neurotoxic processes associated with behavioural alterations. Adolescent CD 1 mice were subjected to ethanol intake using the drinking in the dark ( DID ) procedure, acute MDMA or a combination. Considering that both drugs of abuse cause oxidative stress...

DOI: 10.1111/jnc.12247 (opens in new tab) MDMA Hippocampus Oxidative stress Radial arm maze +4

Modulation of 3,4-methylenedioxymethamphetamine effects by endocannabinoid system.

Current Pharmaceutical Design 2013 Olga Valverde, Marta Rodríguez‐arias

The amphetamine derivative 3, 4 Methylenedioxymethanphetamine (MDMA) is a powerful central nervous system stimulant that displays numerous pharmacological effects, including neurotoxicity. MDMA, or ecstasy, acts by inducing the release of different neurotransmitters depending on the animal species and, in particular, it produces the release of serotonin and dopamine. MDMA induces rewarding and...

Acute blockade of CB1 receptor leads to reinstatement of MDMA-induced conditioned place preference.

Pharmacology, Biochemistry, and Behavior November 2011 Manuel Daza‐losada, José Miñarro, María A. Aguilar et al.

Cannabis is one of the drugs most commonly consumed in combination with ecstasy (3,4-methylenedioxymethamphetamine, MDMA). Although numerous studies have attempted to further our understanding of the role of the cannabinoid system in drug abuse, few have focused on how it influences the rewarding effects of MDMA. The aim of the present study was to evaluate the role of the CB1 cannabinoid...

The A2a adenosine receptor modulates the reinforcement efficacy and neurotoxicity of MDMA

Journal of Psychopharmacology January 24, 2011 Jéssica Ruiz‐medina, Catherine Ledent, Olga Carretón et al. 33 citations

Adenosine is an endogenous purine nucleoside that plays a neuromodulatory role in the central nervous system. A2a adenosine receptors have been involved in reward-related processes, inflammatory phenomena and neurotoxicity reactions. In the present study, we investigated the role of A2a adenosine receptors on the acute pharmacological effects, reinforcement and neuroinflammation induced by MDMA...

DOI: 10.1177/0269881110389210 (opens in new tab) MDMA Neurotoxicity Adenosine a2a receptor Pharmacology +6

THC Prevents MDMA Neurotoxicity in Mice

PLoS One February 10, 2010 Clara Touriño, Andreas Zimmer, Olga Valverde 55 citations

The majority of MDMA (ecstasy) recreational users also consume cannabis. Despite the rewarding effects that both drugs have, they induce several opposite pharmacological responses. MDMA causes hyperthermia, oxidative stress and neuronal damage, especially at warm ambient temperature. However, THC, the main psychoactive compound of cannabis, produces hypothermic, anti-inflammatory and...

DOI: 10.1371/journal.pone.0009143 (opens in new tab) MDMA Am251 Neurotoxicity Pharmacology +3

CB1 cannabinoid receptor modulates 3,4-methylenedioxymethamphetamine acute responses and reinforcement.

Biological Psychiatry June 1, 2008 Clara Touriño, Catherine Ledent, Rafaël Maldonado et al.

3,4-Methylenedioxymethamphetamine (MDMA) is a popular recreational drug widely abused by young people. The endocannabinoid system is involved in the addictive processes induced by different drugs of abuse. However, the role of this system in the pharmacological effects of MDMA has not yet been clarified. Locomotion, body temperature, and anxiogenic-like responses were evaluated after acute MDMA...

MDMA attenuates THC withdrawal syndrome in mice.

Psychopharmacology July 2007 Clara Touriño, Rafaël Maldonado, Olga Valverde

3, 4-Methylenedioxymethamphetamine (MDMA) and cannabis are widely abused illicit drugs that are frequently consumed in combination. Interactions between these two drugs have been reported in several pharmacological responses observed in animals, such as body temperature, anxiety, cognition, and reward. However, the interaction between MDMA and cannabis in addictive processes such as physical...

Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC.

European Journal of Neuroscience October 2004 Guadalupe Soria, Anna Castañé, Fernando Berrendero et al.

A2A adenosine and CB1 cannabinoid receptors are highly expressed in the central nervous system, where they modulate numerous physiological processes including adaptive responses to drugs of abuse. Both purinergic and cannabinoid systems interact with dopamine neurotransmission (through A2A and CB1 receptors, respectively). Changes in dopamine neurotransmission play an important role in...

Absence of delta -9-tetrahydrocannabinol dysphoric effects in dynorphin-deficient mice.

Journal of Neuroscience December 1, 2001 Andreas Zimmer, E Valjent, M Konig et al.

The involvement of dynorphin on Delta-9-tetrahydrocannabinol (THC) and morphine responses has been investigated by using mice with a targeted inactivation of the prodynorphin (Pdyn) gene. Dynorphin-deficient mice show specific changes in the behavioral effects of THC, including a reduction of spinal THC analgesia and the absence of THC-induced conditioned place aversion. In contrast, acute and...

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

Science January 15, 1999 Catherine Ledent, Olga Valverde, G Cossu et al.

The function of the central cannabinoid receptor (CB1) was investigated by invalidating its gene. Mutant mice did not respond to cannabinoid drugs, demonstrating the exclusive role of the CB1 receptor in mediating analgesia, reinforcement, hypothermia, hypolocomotion, and hypotension. The acute effects of opiates were unaffected, but the reinforcing properties of morphine and the severity of...